News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,741 Results
Type
Article (8587)
Company Profile (148)
Press Release (481003)
Multimedia
Podcasts (6)
Webinars (8)
Section
Business (167852)
Career Advice (319)
Deals (25903)
Drug Delivery (9)
Drug Development (53632)
Employer Resources (15)
FDA (9882)
Job Trends (8674)
News (240011)
Policy (18041)
Tag
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (507)
Accelerated approval (28)
ADA (19)
Adcomms (6)
Allergies (104)
Alliances (33487)
ALS (109)
Alzheimer's disease (993)
Antibody-drug conjugate (ADC) (301)
Approvals (10494)
Artificial intelligence (340)
ASCO (162)
Autoimmune disease (223)
Automation (29)
Bankruptcy (264)
Belgium (2)
Best Places to Work (7015)
BIO (37)
Biologics (9)
BIOSECURE Act (5)
Biosimilars (115)
BioSpace Insights (17)
Biotechnology (96)
Bispecific (1)
Bladder cancer (139)
Brain cancer (32)
Breast cancer (521)
Cancer (3812)
Cardiovascular disease (232)
Career advice (251)
Career pathing (1)
CAR-T (188)
CDC (2)
CDMO (19)
Celiac Disease (1)
Cell therapy (520)
Cervical cancer (35)
Clinical research (48560)
Collaboration (1315)
Commercialization (3)
Compensation (1533)
Complete response letters (37)
COVID-19 (830)
CRISPR (70)
C-suite (831)
Cystic fibrosis (88)
Data (5920)
Denatured (4)
Depression (106)
Dermatology (68)
Diabetes (359)
Diagnostics (4229)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (162)
Drug pricing (8)
Drug shortages (2)
Duchenne muscular dystrophy (167)
Earnings (73856)
Editorial (4)
Employer branding (2)
Employer resources (15)
Events (88713)
Executive appointments (735)
FDA (12620)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (983)
Gene editing (135)
Generative AI (11)
Gene therapy (362)
GLP-1 (307)
Government (978)
Grass and pollen (2)
Guidances (283)
Healthcare (9482)
Hematology (97)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (116)
Immuno-oncology (61)
Indications (162)
Infectious disease (1024)
Inflammatory bowel disease (135)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (262)
Interviews (43)
IPO (12457)
IRA (2)
Job creations (2003)
Job search strategy (241)
JPM (3)
Kidney cancer (16)
Labor market (5)
Layoffs (74)
Legal (5206)
Licensing (18)
Liver cancer (46)
Longevity (19)
Lung cancer (548)
Lymphoma (261)
Machine learning (30)
Management (4)
Manufacturing (574)
Marketing (9)
MASH (120)
Medical affairs (2)
Medical device (8701)
Medtech (8860)
Mergers & acquisitions (14516)
Metabolic disorders (735)
mRNA (68)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (235)
Neuropsychiatric disorders (40)
Neuroscience (1891)
NextGen: Class of 2026 (3197)
Non-profit (859)
Now hiring (4)
Obesity (233)
Opinion (14)
Ovarian cancer (163)
Pain (184)
Pancreatic cancer (207)
Parkinson's disease (209)
Partnered (12)
Patents (498)
Patient recruitment (537)
Patient selection (2)
Peanut (32)
People (41782)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15805)
Phase 2 (21744)
Phase 3 (14620)
Pipeline (7749)
Policy (30)
Postmarket research (1569)
Preclinical (6632)
Press Release (34)
Prostate cancer (194)
Psychedelics (8)
Radiopharmaceuticals (195)
Rare diseases (611)
Real estate (3077)
Recruiting (6)
Regenerative medicine (2)
Regulatory (15087)
Reports (25)
Research institute (603)
Resumes & cover letters (48)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (177)
Series B (124)
Service/supplier (5)
Sickle cell disease (64)
Special edition (2)
Spinal muscular atrophy (92)
Sponsored (6)
Startups (2067)
Stomach cancer (3)
Supply chain (52)
Tariffs (2)
The Weekly (2)
Vaccines (335)
Venture capital (20)
Weight loss (77)
Women's health (89)
Date
Last 7 days (288)
Last 30 days (1344)
Last 365 days (19231)
2026 (13763)
2025 (19536)
2024 (23228)
2023 (26835)
2022 (34985)
2021 (37562)
2020 (33753)
2019 (23509)
2018 (17619)
2017 (18938)
2016 (18091)
2015 (24433)
2014 (21799)
2013 (18241)
2012 (20292)
2011 (20547)
2010 (20389)
Location
Africa (239)
Alabama (77)
Alaska (2)
Arizona (310)
Arkansas (11)
Asia (18437)
Australia (2143)
California (12431)
Canada (3273)
China (576)
Colorado (497)
Connecticut (427)
Delaware (218)
Europe (25525)
Florida (1856)
Georgia (394)
Hawaii (3)
Idaho (46)
Illinois (727)
India (52)
Indiana (323)
Iowa (16)
Japan (438)
Kansas (103)
Kentucky (33)
Louisiana (27)
Maine (26)
Maryland (1250)
Massachusetts (8217)
Michigan (314)
Minnesota (576)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (60)
New Jersey (2700)
New Mexico (12)
New York (2904)
North Carolina (1319)
North Dakota (4)
Northern California (6246)
Ohio (293)
Oklahoma (14)
Oregon (16)
Pennsylvania (2344)
Puerto Rico (21)
Rhode Island (30)
South America (412)
South Carolina (78)
South Dakota (1)
Southern California (5156)
Tennessee (125)
Texas (2028)
United States (40347)
Utah (372)
Vermont (1)
Virginia (161)
Washington D.C. (39)
Washington State (960)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
489,741 Results for "protalix biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Protalix BioTherapeutics to Present at Investor Summit Virtual
September 12, 2025
·
2 min read
Press Releases
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)
March 9, 2026
·
13 min read
Press Releases
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
February 1, 2026
·
13 min read
Press Releases
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
September 17, 2026
·
4 min read
Press Releases
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU
February 1, 2026
·
9 min read
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics, Inc. announced that Dror Bashan, its President and Chief Executive Officer, will present at the upcoming 2024 BIO International Convention June 3 - 6, 2024, in San Diego, California.
May 29, 2024
·
3 min read
Press Releases
Iovance Biotherapeutics to Present at Upcoming Conferences - September 4, 2026
September 4, 2026
·
3 min read
Business
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
Protalix BioTherapeutics, Inc. reported financial results for the fiscal year ended December 31, 2023, and provided a business update.
March 14, 2024
·
18 min read
Press Releases
First Tracks Biotherapeutics Announces Participation in September 2026 Investor Conferences
August 26, 2026
·
1 min read
Press Releases
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
September 17, 2026
·
3 min read
1 of 48,975
Next
